BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Diagnosis
110 results:

  • 1. Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Gaillard JB; Chapiro E; Daudignon A; Nadal N; Penther D; Chauzeix J; Nguyen-Khac F; Veronese L; Lefebvre C
    Curr Res Transl Med; 2023; 71(4):103428. PubMed ID: 38016421
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Flow cytometric signature of CD371-positive B-cell acute lymphoblastic leukemia.
    Shakah H; Tbakhi A; Khudirat S; Abweh RA; Hasasna N; Alwhaidi A; Khoujah A; Barakat F
    J Int Med Res; 2023 Oct; 51(10):3000605231203842. PubMed ID: 37818740
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Clinical features and prognosis of core binding factor acute myeloid leukemia children in South China: a multicenter study].
    Guo BY; Wang Y; Li J; Li CF; Feng XQ; Zheng MC; Liu SX; Yang LH; Jiang H; Xu HG; He XL; Wen H
    Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):881-888. PubMed ID: 37803854
    [No Abstract]    [Full Text] [Related]  

  • 4. Comparing presentations and outcomes of children with cancer: a study between a lower-middle-income country and a high-income country.
    Farrag A; Ghazaly MH; Mohammed K; Volland R; Hero B; Berthold F
    BMC Pediatr; 2023 Sep; 23(1):443. PubMed ID: 37670249
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic value of combined WT1 and multiparameter flow cytometry assessment for measurable residual disease after induction in non-APL acute myeloid leukemia.
    Ding Y; Liu Z; Wang H; Xiong S; Zhai Z
    Scand J Clin Lab Invest; 2023 Sep; 83(5):340-347. PubMed ID: 37355341
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. SOHO State of the Art Updates and Next Questions | Challenging Cases in Rare T-Cell Lymphomas.
    Bhansali RS; Barta SK
    Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):642-650. PubMed ID: 37302955
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group.
    Sato A; Hatta Y; Imai C; Oshima K; Okamoto Y; Deguchi T; Hashii Y; Fukushima T; Hori T; Kiyokawa N; Kato M; Saito S; Anami K; Sakamoto T; Kosaka Y; Suenobu S; Imamura T; Kada A; Saito AM; Manabe A; Kiyoi H; Matsumura I; Koh K; Watanabe A; Miyazaki Y; Horibe K
    Lancet Haematol; 2023 Jun; 10(6):e419-e432. PubMed ID: 37167992
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. From the archives of MD Anderson Cancer Center: Aleukemic T-prolymphocytic leukemia, a rare presentation and review of the literature.
    Nahmod KA; Thakral B; Aakash FNU; Iyer SP; Medeiros LJ; Quesada AE
    Ann Diagn Pathol; 2023 Feb; 62():152077. PubMed ID: 36549077
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Blastic plasmacytoid dendritic cell neoplasm: A clinicopathological diagnostic dilemma report of three cases with review of literature.
    Purkait S; Gupta S; Bakhshi S; Mallick S
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S471-S474. PubMed ID: 36511007
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.
    Makishima H; Saiki R; Nannya Y; Korotev S; Gurnari C; Takeda J; Momozawa Y; Best S; Krishnamurthy P; Yoshizato T; Atsuta Y; Shiozawa Y; Iijima-Yamashita Y; Yoshida K; Shiraishi Y; Nagata Y; Kakiuchi N; Onizuka M; Chiba K; Tanaka H; Kon A; Ochi Y; Nakagawa MM; Okuda R; Mori T; Yoda A; Itonaga H; Miyazaki Y; Sanada M; Ishikawa T; Chiba S; Tsurumi H; Kasahara S; Müller-Tidow C; Takaori-Kondo A; Ohyashiki K; Kiguchi T; Matsuda F; Jansen JH; Polprasert C; Blombery P; Kamatani Y; Miyano S; Malcovati L; Haferlach T; Kubo M; Cazzola M; Kulasekararaj AG; Godley LA; Maciejewski JP; Ogawa S
    Blood; 2023 Feb; 141(5):534-549. PubMed ID: 36322930
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Small cell variant anaplastic large cell lymphoma presenting as leukemia: A case report and review of Literature.
    Dutta R; Ramteke P; Mathur SR; Saxena R; Pati HP; Mallick S
    Indian J Pathol Microbiol; 2022; 65(3):705-708. PubMed ID: 35900509
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms.
    Fang H; Khoury JD; Torres-Cabala CA; Ng SB; Xu J; El Hussein S; Hu S; Vega F; Li S; Tang Z; Tang G; Medeiros LJ; Wang W
    Pathology; 2022 Dec; 54(7):893-899. PubMed ID: 35864006
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. An investigation of the use of app technology to support clinical management of patients with chronic myeloid leukaemia (CML).
    Khadam S; Chu T; Deekes N; FitzGerald D; Preston A; Duncan N
    J Oncol Pharm Pract; 2023 Jul; 29(5):1083-1093. PubMed ID: 35404173
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.
    García-Sancho AM; Bellei M; López-Parra M; Gritti G; Cortés M; Novelli S; Panizo C; Petrucci L; Gutiérrez A; Dlouhy I; Bastos-Oreiro M; Sancho JM; Ramírez MJ; Moraleda JM; Carrillo E; Jiménez-Ubieto AI; Jarque I; Orsucci L; García-Torres E; Montalbán C; Dodero A; Arranz R; De Las Heras N; Pascual MJ; López-Jiménez J; Spina M; Re A; De Villambrosia SG; Bobillo S; Federico M; Caballero D
    Haematologica; 2022 Nov; 107(11):2675-2684. PubMed ID: 35320921
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Differences in the diagnosis and treatment of hematologic malignancies attributable to health insurance coverage.
    Song EY; Shin S; Park H; Kim N; Yoon JH; Roh EY
    Medicine (Baltimore); 2022 Mar; 101(9):e29020. PubMed ID: 35244084
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Lymphoma versus Carcinoma and Other Collaborations.
    Pulford K
    Cells; 2022 Jan; 11(1):. PubMed ID: 35011737
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cytomegalovirus DNAemia and disease: current-era epidemiology, clinical characteristics and outcomes in cancer patients other than allogeneic haemopoietic transplantation.
    Tay KH; Slavin MA; Thursky KA; Coussement J; Worth LJ; Teh BW; Khot A; Tam CS; Yong MK
    Intern Med J; 2022 Oct; 52(10):1759-1767. PubMed ID: 34448333
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mature T/NK-Cell lymphomas of the oral and maxillofacial region: A multi-institutional collaborative study.
    de Arruda JAA; Abrantes TC; Cunha JLS; Roza ALOC; Agostini M; Abrahão AC; Canedo NHS; Ramos DD; Milito CB; Pontes FSC; Pontes HAR; Barra MB; Zanella VG; Martins MAT; Martins MD; Israel MS; Freire NA; Barreto MEZ; Sánchez-Romero C; Carlos R; Abreu LG; Vargas PA; de Almeida OP; Fonseca FP; Romañach MJ; Mesquita RA; de Andrade BAB
    J Oral Pathol Med; 2021 Jul; 50(6):548-557. PubMed ID: 34091947
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Real-world Prescription Pattern, Discontinuation and Costs of Ibrutinib-Naïve Patients with Chronic Lymphocytic leukemia: An Italian Healthcare Administrative Database Analysis.
    Ronconi G; Dondi L; Calabria S; Piccinni C; Pedrini A; Esposito I; Martini N
    Clin Drug Investig; 2021 Jul; 41(7):595-604. PubMed ID: 34032988
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification of genes associated with Kikuchi-Fujimoto disease using RNA and exome sequencing.
    Anuntakarun S; Larbcharoensub N; Payungporn S; Reamtong O
    Mol Cell Probes; 2021 Jun; 57():101728. PubMed ID: 33819568
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.